Momenta Pharmaceuticals, Inc. (MNTA)

[Boing x 2]

I was leaning the royalty way and the more I thought about it, I am not so sure.

If they try and work out a royalty agreement they admit they infringed on the IP.

MNTA will never make up the difference lost each quarter with a xx royalty payment.

Watson has the deep pockets and MNTA has a right to immediate greater damages if the IP was violated.

I am not sure how the anticompetitive applies when there is supply on the market with two big players.

If I were Watson, I would be making darn sure on the IP.issue.

Time will tell